Glycogen synthase kinase 3 (GSK3)-inhibitor SB216763 promotes the conversion of human umbilical cord mesenchymal stem cells into neural precursors in adherent culture.The ability to generate neural progenitor cells from human umbilical cord mesenchymal stem cells (hUC-MSCs) has provided an option to treat neurodegenerative diseases.  To establish a method for this purpose, we characterized the early neural markers of hUC-MSCs-derived cells under different conditions.  We found that neither the elimination of signals for alternative fate nor N2 supplement was sufficient to differentiate hUC-MSCs into neural precursor cells, but the GSK3 inhibitor SB216763 could promote an efficient neural commitment of hUC-MSCs.  The results indicated that Wnt/β-catenin might play an important role during the early neural differentiation of hUC-MSCs.  Here, we report a method for hUC-MSCs to commit efficiently into a neural fate within a short period of time.  This protocol provides an efficient method for hUC-MSCs-based neural regeneration.
C